OBJECTIVE： To investigate the characteristics and influential factors of adverse drug reactions （ADRs） of docetaxel in our hospital， and to provide suggestions for clinical rational drug use and individualized administration. METHODS： Medical records of patients receiving anti-tumor chemotherapy were extracted from hospital information system （HIS） of our hospital during Apr. 2014 and Oct. 2015， and Docetaxel related ADR reports were collected and comprehensively analyzed by retrospective classified statistics. RESULTS： Among 417 cases， 105 cases of docetaxel related ADR were reported. There were 69 patients aged 50-69 with highest ADR frequency. The ADR incidence of female patients was higher than that of male patients （29.29％ vs. 19.66％）. The incidence of docetaxel related ADR and arrest of bone marrow increased as the increase of drug dosage； the incidence of breast cancer ADR was the highest （46.03％）， followed by lung cancer （37.25％） and gastric cancer （25.00％）. The incidence of docetaxel+platinum chemotherapy plan ADR was the highest （35.10％）. Main organs/system involved in ADR was hematological system （55.65％）. CONCLUSIONS： The individual difference of docetaxal related ADR are great and affected by several factors. Individual physical condition of patients should be taken into consideration as early as possible， which can reduce the incidence of ADR and promote clinical rational drug use.